Last reviewed · How we verify
Linkage to Care and Treatment of Chronic HBV Patients
Chronic hepatitis B remains the leading cause of liver related mortality and morbidity globally and locally. Countries have been formulating initiatives to meet the WHO target of eliminating viral hepatitis by 2030. However, data on the most important aspect of management of chronic hepatitis B, namely linkage to care and treatment, remains scarce. In order to achieve the WHO goal, treatment rate of eligible patients should reach 80%.
Details
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 803 |
| Start date | Sat Apr 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Dec 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hepatitis B, Chronic
Interventions
- Receiving an educational intervention
Countries
Hong Kong